
|Articles|April 1, 2003
Langerhans Update
Bal Harbour, Fla. - Langerhans cell histiocytosis (LCH) is not always an easy diagnosis in children, and even nonsick children with seemingly inconsequential skin LCH should undergo full workups and be closely followed by pediatric oncologists, Ronald C. Hansen, M.D., said at the annual Masters of Pediatrics meeting, hosted by the University of Miami School of Medicine.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
5


















